81133 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-08-31 |
| Register Year | 2013 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | BELIMUMAB |
| Trade Name | BENLYSTA 120MG POWDER FOR SOLUTION FOR INFUSION |
| Strength Unit | mg |
| Pharmaceutical Form | Powder for concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | L04AA26 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $452.7 |
| Shelf Life | 36 Months |
| Marketing Company | Glaxo Saudi Arabia Ltd |
| Marketing Country | Saudi Arabia |
| Manufacture Name | HOSPIRA |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO) |
| Secosnd Agent | |
| Third Agent | |
| Visits | 81133 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Benlysta | $3531.99 | 257452 visits | 2022-08-01 |
| BENLYSTA 120MG POWDER FOR SOLUTION FOR I | $452.7 | 81133 visits | 2022-08-31 |
| BENLYSTA 400MG POWDER FOR SOLUTION FOR I | $1509.1 | 267679 visits | 2022-08-31 |